Overview
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form, is a rare inherited metabolic disorder. It is a specific subtype of glycogen storage disease type IV (GSD IV), also known as Andersen disease or amylopectinosis. In this condition, the body lacks enough of an enzyme called glycogen branching enzyme (GBE), which is needed to build glycogen — the stored form of sugar that provides energy to muscles and other organs. Without this enzyme working properly, an abnormal form of glycogen (similar to a plant starch called amylopectin) builds up in the liver and muscles, causing damage to both organs. Children with this form typically develop symptoms during childhood, including liver problems such as an enlarged liver, liver scarring (cirrhosis), and progressive liver failure, along with muscle weakness and exercise intolerance. The combination of liver and muscle involvement distinguishes this form from other subtypes of GSD IV that may affect only one organ system. There is currently no cure for this condition. Treatment focuses on managing symptoms and complications. Liver transplantation may be considered for children with severe liver disease, though it does not fully address the muscle problems. Supportive care includes physical therapy, nutritional support, and close monitoring of liver and muscle function. Research into potential therapies, including gene therapy and enzyme replacement, is ongoing but not yet available as standard treatment.
Also known as:
Key symptoms:
Enlarged liver (hepatomegaly)Liver scarring (cirrhosis)Progressive liver failureMuscle weaknessPoor exercise toleranceFailure to thrive or poor growthAbdominal swelling from fluid buildup (ascites)Fatigue and low energyYellowing of the skin and eyes (jaundice)Muscle wastingDifficulty with physical activitiesEasy bruising or bleeding due to liver problemsDelayed motor milestones
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form.
Community
No community posts yet. Be the first to share your experience with Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form.
Start the conversation →Latest news about Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form
No recent news articles for Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe is my child's liver and muscle involvement right now, and how will you monitor it over time?,Is liver transplantation something we should be considering, and when would that decision need to be made?,What dietary changes or supplements should my child follow?,What physical activities are safe, and what should we avoid?,Are there any clinical trials or experimental treatments available for this condition?,What emergency signs should I watch for at home, and what should I do if they occur?,Should other family members be tested for carrier status, and what does this mean for future pregnancies?
Common questions about Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form
What is Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form?
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form, is a rare inherited metabolic disorder. It is a specific subtype of glycogen storage disease type IV (GSD IV), also known as Andersen disease or amylopectinosis. In this condition, the body lacks enough of an enzyme called glycogen branching enzyme (GBE), which is needed to build glycogen — the stored form of sugar that provides energy to muscles and other organs. Without this enzyme working properly, an abnormal form of glycogen (similar to a plant starch called amylopectin) bu
How is Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form inherited?
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form typically begin?
Typical onset of Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form is childhood. Age of onset can vary across affected individuals.